Orbimed Advisors - VERA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of VERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,813,357
-26.2%
1,518,115
-13.6%
0.44%
-13.5%
Q2 2023$28,196,640
+166.7%
1,756,800
+28.9%
0.51%
+145.7%
Q1 2023$10,572,2241,362,4000.21%
Other shareholders
VERA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Abingworth LLP 2,960,231$57,280,47018.66%
Kynam Capital Management, LP 1,409,098$27,266,0464.18%
Sofinnova Investments, Inc. 3,181,442$61,560,9033.65%
Octagon Capital Advisors LP 665,156$12,870,7692.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 281,257$5,428,2601.68%
Vivo Capital, LLC 400,666$7,7530.89%
Eversept Partners, LP 411,308$7,958,8100.70%
Logos Global Management LP 285,000$5,514,7500.65%
Alphabet Inc. 301,580$5,835,5730.34%
CARNEGIE MELLON UNIVERSITY 16,060$310,7610.17%
View complete list of VERA THERAPEUTICS INC shareholders